Literature DB >> 25663016

Rapid parallel synthesis of bioactive folded cyclotides by using a tea-bag approach.

Teshome Aboye1, Yuting Kuang, Nouri Neamati, Julio A Camarero.   

Abstract

We report here the first rapid parallel production of bioactive folded cyclotides by using Fmoc-based solid-phase peptide synthesis in combination with a "tea-bag" approach. Using this approach, we efficiently synthesized 15 analogues of the CXCR4 antagonist cyclotide MCo-CVX-5c. Cyclotides were synthesized in a single-pot, cyclization/folding reaction in the presence of reduced glutathione. Natively folded cyclotides were quickly purified from the cyclization/folding crude mixture by activated thiol Sepharose-based chromatography. The different folded cyclotide analogues were then tested for their ability to inhibit the CXCR4 receptor in a cell-based assay. The results indicated that this approach can be used for the efficient chemical synthesis of libraries of cyclotides with improved biological properties that can be easily interfaced with solution or cell-based assays for rapid screening.
© 2015 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.

Entities:  

Keywords:  CXCR4; cyclotides; protein design; protein engineering; protein-protein interactions

Mesh:

Substances:

Year:  2015        PMID: 25663016      PMCID: PMC4440831          DOI: 10.1002/cbic.201402691

Source DB:  PubMed          Journal:  Chembiochem        ISSN: 1439-4227            Impact factor:   3.164


  42 in total

1.  General method for the rapid solid-phase synthesis of large numbers of peptides: specificity of antigen-antibody interaction at the level of individual amino acids.

Authors:  R A Houghten
Journal:  Proc Natl Acad Sci U S A       Date:  1985-08       Impact factor: 11.205

2.  Circular proteins in plants: solution structure of a novel macrocyclic trypsin inhibitor from Momordica cochinchinensis.

Authors:  M E Felizmenio-Quimio; N L Daly; D J Craik
Journal:  J Biol Chem       Date:  2001-04-05       Impact factor: 5.157

3.  Studies on the structural requirement for ligand binding to the neuropeptide Y (NPY) receptor from rat cerebral cortex.

Authors:  C R Baeza; A Undén
Journal:  FEBS Lett       Date:  1990-12-17       Impact factor: 4.124

4.  Biosynthesis and insecticidal properties of plant cyclotides: the cyclic knotted proteins from Oldenlandia affinis.

Authors:  C Jennings; J West; C Waine; D Craik; M Anderson
Journal:  Proc Natl Acad Sci U S A       Date:  2001-09-04       Impact factor: 11.205

5.  Chemical and biomimetic total syntheses of natural and engineered MCoTI cyclotides.

Authors:  Panumart Thongyoo; Núria Roqué-Rosell; Robin J Leatherbarrow; Edward W Tate
Journal:  Org Biomol Chem       Date:  2008-03-06       Impact factor: 3.876

6.  Design of a novel cyclotide-based CXCR4 antagonist with anti-human immunodeficiency virus (HIV)-1 activity.

Authors:  Teshome L Aboye; Helen Ha; Subhabrata Majumder; Frauke Christ; Zeger Debyser; Alexander Shekhtman; Nouri Neamati; Julio A Camarero
Journal:  J Med Chem       Date:  2012-11-27       Impact factor: 7.446

7.  Biosynthesis and biological screening of a genetically encoded library based on the cyclotide MCoTI-I.

Authors:  Jeffrey Austin; Wan Wang; Swamy Puttamadappa; Alexander Shekhtman; Julio A Camarero
Journal:  Chembiochem       Date:  2009-11-02       Impact factor: 3.164

Review 8.  Cyclotides as templates in drug design.

Authors:  Sónia Troeira Henriques; David J Craik
Journal:  Drug Discov Today       Date:  2009-10-28       Impact factor: 7.851

Review 9.  Discovery, structure and biological activities of cyclotides.

Authors:  Norelle L Daly; K Johan Rosengren; David J Craik
Journal:  Adv Drug Deliv Rev       Date:  2009-05-23       Impact factor: 15.470

Review 10.  The AMD3100 story: the path to the discovery of a stem cell mobilizer (Mozobil).

Authors:  Erik De Clercq
Journal:  Biochem Pharmacol       Date:  2008-12-31       Impact factor: 5.858

View more
  9 in total

1.  In vivo Evaluation of an Engineered Cyclotide as Specific CXCR4 Imaging Reagent.

Authors:  Wojciech G Lesniak; Teshome Aboye; Samit Chatterjee; Julio A Camarero; Sridhar Nimmagadda
Journal:  Chemistry       Date:  2017-08-03       Impact factor: 5.236

2.  Full Sequence Amino Acid Scanning of θ-Defensin RTD-1 Yields a Potent Anthrax Lethal Factor Protease Inhibitor.

Authors:  Yilong Li; Andrew Gould; Teshome Aboye; Tao Bi; Leonard Breindel; Alexander Shekhtman; Julio A Camarero
Journal:  J Med Chem       Date:  2017-02-14       Impact factor: 7.446

Review 3.  Using backbone-cyclized Cys-rich polypeptides as molecular scaffolds to target protein-protein interactions.

Authors:  Dipankar Chaudhuri; Teshome Aboye; Julio A Camarero
Journal:  Biochem J       Date:  2019-01-11       Impact factor: 3.857

Review 4.  Cyclotides: Overview and Biotechnological Applications.

Authors:  Andrew Gould; Julio A Camarero
Journal:  Chembiochem       Date:  2017-05-24       Impact factor: 3.164

Review 5.  Cyclotides, a versatile ultrastable micro-protein scaffold for biotechnological applications.

Authors:  Julio A Camarero
Journal:  Bioorg Med Chem Lett       Date:  2017-10-21       Impact factor: 2.823

6.  Chemical and biological production of cyclotides.

Authors:  Yilong Li; Tao Bi; Julio A Camarero
Journal:  Adv Bot Res       Date:  2015       Impact factor: 2.175

Review 7.  The Potential of the Cyclotide Scaffold for Drug Development.

Authors:  Julio A Camarero; Maria Jose Campbell
Journal:  Biomedicines       Date:  2019-04-19

Review 8.  Using the Cyclotide Scaffold for Targeting Biomolecular Interactions in Drug Development.

Authors:  Binu Jacob; Alicia Vogelaar; Enrique Cadenas; Julio A Camarero
Journal:  Molecules       Date:  2022-09-29       Impact factor: 4.927

9.  Engineered Cyclotides with Potent Broad in Vitro and in Vivo Antimicrobial Activity.

Authors:  Rajasekaran Ganesan; Mansour A Dughbaj; Lisa Ramirez; Steven Beringer; Teshome L Aboye; Alexander Shekhtman; Paul M Beringer; Julio A Camarero
Journal:  Chemistry       Date:  2021-08-06       Impact factor: 5.020

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.